Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Glioma candidate pritumumab receives U.S. orphan drug designation

Nov. 3, 2014

Kurume University discloses new cancer antigen peptide vaccines

Oct. 29, 2014

Biothera announces phase Ib trial of mucin-1-targeted antibody BTH-1704 and Imprime PGG

Oct. 28, 2014

Medivation licenses anti-PD-1 antibody pidilizumab from CureTech

Oct. 24, 2014

EMA grants orphan drug designation to isactuzumab govitecan

Oct. 21, 2014

Nivolumab and ipilimumab combination receives FDA orphan drug designation

Oct. 16, 2014

Advaxis reports preliminary data from phase I/II trial of ADXS-HPV in anal cancer

Oct. 16, 2014

Phase I data for MPDL-3280A for the treatment of UBC and other malignancies

Oct. 15, 2014

GAPVAC consortium advances a personalized cancer vaccine approach into the clinic for glioblastoma

Oct. 15, 2014

FDA accepts BLA for blinatumomab in acute lymphoblastic leukemia

Oct. 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...